Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2448-2023Class II

Randox Liquid Protein Calibrators-SP CAL-(LIQ)-In vitro diagnostic product used for the calibration of ASO...

Randox Laboratories, Limited / initiated 2023-07-19 / Open, Classified / root cause: manufacturing process

Randox Laboratories Ltd. began a recall of Randox Liquid Protein Calibrators-SP CAL-(LIQ)-In vitro diagnostic product used for the calibration of ASO, Complement C3, Complement C4, CRP, Ferritin... on . FDA classified it as Class II and gives the reason as "As part of the firm's ongoing quality monitoring (see internal complaint # OCC72574), Randox Laboratories have restandardized Ferritin in Liquid Protein Calibrators, IT2691, to reference material NISBC 19/118. The...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2448-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Randox Laboratories, Limited
Product
Randox Liquid Protein Calibrators-SP CAL-(LIQ)-In vitro diagnostic product used for the calibration of ASO, Complement C3, Complement C4, CRP, Ferritin, Haptoglobin, IgM, Prealbumin, RF and Transferrin assays Catalogue Number: IT2691
Product code
JIX Calibrator, Multi-Analyte Mixture
Reason for recall
As part of the firm's ongoing quality monitoring (see internal complaint # OCC72574), Randox Laboratories have restandardized Ferritin in Liquid Protein Calibrators, IT2691, to reference material NISBC 19/118. The calibrators lots 2112IT-2116IT, packed into batches 627222, 627224, 634886 and 634887 have been reassigned as part of the restandardization. Following this restandardization, Ferritin results for Quality Control material and patient samples recovered erroneously higher than the targeted calibrator values by approximately +10% across the assay range following.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
Randox Labs Ltd (Manufacturer) extended recall to the US distributor via Medical Device Correction Letter dated July 19, 2023. The distributor initial contact with customer and follow up contacts via email and telephone. Letter states reason for recall, health risk and action to take: " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to [email protected] within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organisation. If you have any questions or concerns please contact Rand ox Technical Services. Any customers using batches 590858 and 590859 for Ferritin, please contact [email protected]
Quantity in commerce
166 units
Distribution
CA, FL, IL, ME, MI, NC, OH, PA,NJ,
Product codes and lots
GTIN: 05055273204032 Batch/ Lot number Expiry Date 590858 28 08 23; 590859 28 08 23; 627222 28Jul 24; 627224 28Jul24; 634886 28Jul24; 634887 28Jul24

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2448-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2448-2023Class IIOngoingVoluntary: Firm initiated